Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Targanta Therapeutics Corp. (TARG) since 2007 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data at Targanta Therapeutics Corp.. Table 2 shows the detailed insider transactions. The reporting company's CIK number is 1398161.
Total stock buying since 2007: $15,500,000.
Total stock sales since 2007: $0.
Total stock option exercises since 2007: $0.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2007 | 1,550,000 | $15,500,000 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2007-10 | 1,550,000 | $15,500,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2007-10-15 | Venkatesan Jay (Director) | Buy | 575,000 | 10.00 | 5,750,000 |
| 2007-10-15 | Gordon Eric M (Director) | Buy | 400,000 | 10.00 | 4,000,000 |
| 2007-10-15 | Brookside Capital Partners Fund Lp (10% Owner) | Buy | 575,000 | 10.00 | 5,750,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of TARG listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Targanta Therapeutics Corp. (symbol TARG, CIK number 1398161) see the Securities and Exchange Commission (SEC) website.